Pharmaceuticals 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 18.
New IMI Projects To Revitalise Antibiotic Development
Recently the Innovative Medicines Initiative (IMI) is launching the first two projects under its antimicrobial resistance (AMR) research programme, ‘New Drugs for Bad Bugs’ (ND4BB).
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news
Court Shuts Down U.S. Operations Of California Drug, Dietary Supplement Manufacturer
A federal judge has ordered a California company and its owner to stop manufacturing and distributing drugs and dietary supplements in domestic commerce until their manufacturing operations comply with the Federal Food, Drug, and Cosmetic Act (the Act).
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news
Kaiser union election rerun set for April
A long-awaited election rerun between two health care unions battling to represent more than 43,500 workers at Kaiser Permanente will be held in April.
Ballots will be mailed to workers on April 5. The vote count is scheduled for May 1.
About 4,000 workers in the Sacramento area are among the service, technical and clerical workers voting to: keep Service Employees International Union-United Healthcare Workers West as their union, replace it with the National Union for Healthcare Workers, a rival…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research
Efforts to Cut Salt Content Take Hold
Twenty-one U.S. companies have reduced salt content in pre-packaged or restaurant foods as part of an effort led by New York Mayor Michael Bloomberg to slash the amount of sodium in the national diet.
Source: WSJ.com: Health - February 11, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
Hawaii Advanced Imaging Institute open at Hale Pawaa in Honolulu
The Hale Pawaa medical office building in Honolulu is continuing to grow its roster of tenants, most recently with the opening of the Hawaii Advanced Imaging Institute’s new 7,000-square-foot facility.
The ground-floor facility, which PBN wrote about in its construction phase this fall, started seeing patients in December and offers technology such as the GE 3t Open MRI scanner, which is larger than typical MRI machines, as well as its 3.0 Tesla MRI, which provides clearer images and reduces the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Source Type: research
The Stress Trophy Should Not Just Go to Millennials
Stress is a hot button issue for adults 18 to 33 years old, otherwise known as the Millennial generation. And it?s keeping many of them up at night according to a new poll released by the American Psychological Association, Stress in America: The Missing Health Care Connection.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Judy Martin Source Type: news
FDA rejects Novo Nordisk insulin remedy
Shares in Danish drugmaker fall 13%, wiping DKr80bn from its market value, as US watchdog requests further tests into potential heart risks
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news
EpiCept Corporation And Immune Pharmaceuticals Amend Merger Agreement
Regulatory News: Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation announced recently that they have executed an amendment to the Merger Agreement and Plan of Reorganization that they signed on November 7, 2012
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news
Sun Pharma, Taro terminate merger deal
India’s Sun Pharmaceutical Industries has terminated its agreement to takeover its Israeli unit Taro Pharmaceutical Industries in a deal worth $571 million.
Source: Pharmaceutical Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news
SMC approve stroke prevention drug Eliquis for use within NHS Scotland
Stroke prevention drug Eliquis has been approved for use within the Scottish NHS, developers Bristol-Myers Squibb and Pfizer have announced.
Source: Pharmaceutical Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news
Synageva commences Phase III ARISE trial of sebelipase alfa
Clinical stage biopharmaceutical company Synageva BioPharma has commenced dosing in its Phase III acid lipase replacement investigating safety and efficacy (ARISE) trial of Sebelipase Alfa in patients with late onset lysosomal acid lipase deficiency …
Source: Drug Development Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news
FDA approves Pomalyst multiple myeloma therapy
The US Food and Drug Administration (FDA) has approved advanced multiple myeloma therapy Pomalyst (pomalidomide) for patients whose disease progressed after being treated with other cancer therapeutics.
Source: Drug Development Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news
Ten Business Trends From The Trenches For 2013
By Andrea Simon, Ph.D.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: WomensMedia Source Type: news
Healthcare's Pricing Cabal
Of all the trending (and trendy) topics in healthcare today, pricing transparency has grown quickly in popularity and focus. Whole companies are now committed to cracking this "secret code,? and then selling the information to us (as either employers or consumers) as a way to enable pricing comaprison for healthcare services. The wisdom, of course, is that if we knew pricing we
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Dan Munro Source Type: news
Are You Ready for the DNA Gun?
VideoThe latest edition of "Mind Blow" (by VSauce2) on YouTube includes a snippet about a DNA Gun that shoots invisible, synthetic DNA at criminals (or anyone else for that matter) which adheres to their skin and makes them trackable. Here's the original story on The Daily Mail; video below.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: David DiSalvo Source Type: news
Bad Medicine Infiltrates MD Anderson Cancer Center
MD Anderson Cancer Center's Director of Integrative Medicine wants to offer acupuncture to all cancer patients. He is highly biased and woefully mistaken.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Steven Salzberg Source Type: news
Apax sells part of stake in Apollo for Rs 530 crore
Private equity firm Apax Partners sold 63.85 lakh shares of Apollo Hospitals Enterprise for Rs 530 crore via a bulk deal on the BSE to Oppenheimer Funds Inc.
Source: The Economic Times Healthcare and Biotech News - February 11, 2013 Category: Pharmaceuticals Source Type: news
Years of fun in the sun mean big business for local lab
Skin cancer and other skin lesions are on the rise as people live longer and more Americans are moving to sunny climes, and a Dallas dermatologist is positioning to take advantage of those demographic trends.
Dr. Clay Cockerell, a dermatopathologist and dermatologist, recently purchased a 78,000-square-foot medical building in the heart of the Dallas Medical District and plans to build an independent laboratory called Cockerell Dermatopathology. It’s projected for completion this summer. He declined…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research
New Privacy Rules May Distract Doctors From Patient Care
My patients needed a lot of my time today. They had questions and concerns. They didn't feel well. They were short of breath, had chest pain or diarrhea or influenza or all three. The practice of medicine isn't simple.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Peter Lipson Source Type: news
UAB to soon begin search for permanent med school dean
The University of Alabama at Birmingham may spend little time without a permanent medical school dean.
In a statement sent to me today, UAB announced that the search for a permanent replacement to Ray Watts, named university president Friday, will start in a few weeks.
Until a permanent choice is made, Anupam Agarwal, a noted physician and academic leader at UAB, will fill the vacancy. UAB also announced last week that Agarwal was not seeking to remain in the medical school dean position permanently.
Watts,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Yann Ranaivo Source Type: research
Earnings: Brookdale losses deepen in 4Q
Brookdale Senior Living Inc.’s losses deepened in the fourth quarter compared to the same period a year ago. The company (NYSE: BKD) posted a loss of $24.4 million, or 20 cents per share, on revenue of $699 million. Analysts, on average, had estimated a loss of seven cents per share on revenue of $699 million, according to Thomson Reuters.
"We had a strong finish to the year as evidenced by the fourth quarter's occupancy increases across our segments and another good entry fee sales quarter. We…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: E.J. Boyer Source Type: research
UC Davis names interim replacement for Pomeroy
Tom Nesbitt has agreed to serve as interim vice chancellor of human health sciences and interim dean of the School Of Medicine when Dr. Claire Pomeroy steps down June 2, UC Davis Chancellor Linda Katehi announced Monday.
A board certified family physician, he oversees the telemedicine program at UC Davis as associate vice chancellor for strategic technologies and alliances. Nesbitt will step down from the interim position when a new executive is selected.
Pomeroy recently accepted a new job as…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research
Suture Health plans to add employees as contracts grow
Suture Health Inc. plans to double its staff of six within the next year as it works with companies with larger patient loads.
The Birmingham-based company, which operates out of Innovation Depot, offers a service that allows physicians to log into a portal and electronically sign medical documents.
Michael Blackstone, the company's founder, said Suture’s portal, known as SutureSign, services roughly 300 health care agencies, most of which average 300 to 500 patients.
But he said Suture is close…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Yann Ranaivo Source Type: research
Victory Pharma set to repay $140,000 to Illinois' Medicaid program
A specialty pharmaceutical company based in California will pay Illinois’ Medicaid program nearly $140,000 for filing false claims, Illinois Attorney General Lisa Madigan announced Monday.
Victory Pharma Inc. allegedly offered kickbacks to physicians who encouraged Medicaid patients to use drugs such as Naprelan, Xodol, Fexmid and Dolgic.
Illinois is not the only beneficiary of the settlement. According to Madigan’s office, Victory Pharma Inc. is set to pay $12 million to Medicaid, Medicare…
Source: bizjournals.com Health Care:Biotechnology headlines - February 11, 2013 Category: Biotechnology Authors: Samantha Liss Source Type: research
Midtown Medical changes name to Elica Health Centers
Midtown Medical Center for Children and Families, a nonprofit clinic that became Sacramento’s newest federally qualified health center last year, has changed its name to Elica Health Centers.
One reason the clinic changed its name is that it currently has two sites — one on J Street in midtown and the other in West Sacramento — and is poised for more growth to meet demand when hundreds of additional patients gain access to care under federal health reform in 2014.
Pronounced “Eleeka,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research
Harnessing IT to Strengthen Relationships
Connecting key information systems assures your suppliers all pull in the right direction
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Outsourcing Excellence in China and India
Close collaboration effectively manages far-flung partnerships
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
DOJ to Treat Manufacturing Regulations as 'Top Area of Focus'
In a notable shift, the US Department of Justice (DOJ) is has announced that current good manufacturing practices (CGMPs) will be one of the agency's "top areas of focus" in the coming year, opening up new areas of uncertainty for those involved in compliance and regulatory activities for the pharmaceutical industry.
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
That Vitamin D You're Taking? It May Not Be What It Appears
According to research released today by Kaiser Permanente, the bottles of vitamin D on drugstore shelves may not contain nearly as much actual active vitamin as they say they do. In fact, some bottles may contain as little as 9% of the vitamin D promised on the label.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Melanie Haiken Source Type: news
World's Biggest Givers
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
In Reddit AMA, Bill Gates Discusses Vaccines, Climate Change, And Steve Jobs
You can learn a lot about the world's most generous man when he does an AMA ("ask me anything") on the popular Web site Reddit.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
e-Therapeutics plans to raise £40m
The funds raised will include substantial further investment by Invesco Asset Management, increasing its shareholding from 45.9% to 49.9%
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news
Perrigo expands UK presence
The Nasdaq-quoted group has paid more than four times the £40m annual sales of Rosemont, a Leeds-based business that sells 150 products
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news
Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling that temporarily locks a key drug out the world’s biggest and most profitable drug market
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of RandD
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Ironwood Pharmaceuticals, Inc. (IRWD) today announced the promotion of Mark Currie, Ph.D. to senior vice president, chief scientific officer (CSO), and president of research and development (R&D).
... Biopharmaceuticals, PersonnelIronwood Pharmaceuticals
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
Repros Therapeutics Corporate Update
Enrollment in 6 Month Open Label Study Near Completion
FDA Meeting Request Submitted
Joachim F. Wernicke, Ph.D, M.D., Named Chief Medical Officer
Company to Present at BIO CEO in NYC February 11, 2013
THE WOODLANDS, Texas, Feb. 11, 2013 -- (Hea... Biopharmaceuticals, FDA, PersonnelRepros Therapeutics, Androxal, Proellex
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
The Sunshine Act Is Finally Final
This article was created due to the hard work of Scott Liebman and Christine Bradshaw of Porzio, Bromberg and Newman. Both can be reached for further comment through the firms site. You can also follow me or Scott on twitter: @ScottLiebmanPLS or @nic_fisher.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Nicole Fender Fisher Source Type: news
Social Media Watchers Stunned: Pope Benedict XVI Resignation Forsakes Twitter
Pope Benedict XVI has become the first pontiff to resign since the 15th century. The leader of the world's more than 1 billion Roman Catholic worshippers cited health reasons behind his wish to step down, effective February 28.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: David Kroll Source Type: news
Stretta(R) Therapy for GERD Receives Strongest Recommendation in SAGES New Clinical Guideline
Quality of Evidence: (++++)
Grade Recommendation: Strong (Highest)
GREENWICH, Conn., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Mederi Therapeutics Inc. today announced that the Society of American Gastrointestinal and Endoscopic Sur... Devices, GastroenterologyMederi Therapeutics, Stretta therapy, GERD , radiofrequency
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
Alliqua Demonstrates Wound Healing Benefit of SilverSeal(R) Dressing on Foot and Ankle Post-Surgical Wounds
Reduction in Scarring and Incidence of Infections Observed
NEW YORK, Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Alliqua, Inc. (ALQA) ("Alliqua" or the "Company") today announced interim results from a post-marketing ... Devices, Wound CareAlliqua, SilverSeal, wound dressing
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
WAYNE, N.J., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for riociguat, an investig... BiopharmaceuticalsBayer HealthCare, riociguat, pulmonary arterial hypertension, CTEPH
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
ZUG, Switzerland, February 11, 2013 -- (Healthcare Sales & Marketing Network) --Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular morta... Biopharmaceuticals, CardiologyCardiorentis, TRUE-AHF, ularitide, heart failure
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
TranS1 Inc. Announces Coverage Milestone
WILMINGTON, N.C., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- TranS1 Inc. (TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region, ann... Devices, Neurosurgery, Orthopaedic, ReimbursementTranS1, pre-sacral interbody fusion, interbody fusion, AxiaLIF, spine surgery
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news
Meat, Fat, Insulin And Other Health News To Start Your Morning
A bunch of health links and thoughts to start your week:
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
Public can see pharma payments to doctors starting in 2014
Revisions in the final transparency rule will give physicians more time to resolve payment amounts and won’t require disclosure of indirect pay from accredited education programs.
Source: American Medical News - GOVERNMENT - February 11, 2013 Category: American Health Source Type: news
Regulatory Concerns Aren't The Only Roadblock In Developing Patient Interaction Strategies
The biggest challenge to pharmaceutical companies implementing patient-centered programs is a failure to communicate priorities effectively between patient adherence teams and both marketing and legal teams, according to a study by Cutting Edge Information.
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news
NETZSCH Announces Appointment of New Pharmaceutical Business Development Manager
Today, NETZSCH Premier Technologies announced that Rajesh Mukherjee has joined the company as the Business Development Manager for Pharmaceutical Applications, located in Exton, PA.
Source: Pharmaceutical Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news
02.12.12 -- Pharmaceutical Track & Trace: A Year In Review
02/12/12 Pharmaceutical Online Newsletter
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news
New 3-D Control Opens Wealth Of Options For Drug Makers
A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment. They report their results in the journal Science. Drug molecules interact with their targets, such as proteins or enzymes, by attaching to them in a way that neutralizes the target's undesirable effects in the body. This is sometimes called the "lock-and-key" method...
Source: Health News from Medical News Today - February 11, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news
